Search research articles
Contact Us
Filters
Showing results (151-160 of 274) with videos related to
Page
of 28
Sort By:
Clinical Lymphoma, Myeloma & Leukemia
|
June 1, 2010
Comparison among immunologically different subtypes of 595 untreated multiple myeloma patients in northern China
Li Zhang, Jun-Yuan Qi, Pei-Jing Qi, et al.
Zhongguo Shi Yan Xue Ye Xue Za Zhi
|
June 18, 2019
[Clinical Analysis of B-CLPD with Cytopemia as the Predominant Characteristic]
Rui Lu, Zeng-Jun Li, Gang An, et al.
JAMA Network Open
|
December 1, 2023
Whole-Exome Sequencing Among School-Aged Children With High Myopia
Xiangyi Yu, Jian Yuan, Zhen Ji Chen, et al.
Blood Advances
|
September 3, 2025
Monoclonal gammopathy defines distinct clinical subsets in Chronic Lymphocytic Leukemia across therapeutic eras
Yuting Yan, Bolin Yuan, Tonglu Qiu, et al.
Zhongguo Shi Yan Xue Ye Xue Za Zhi
|
March 3, 2011
[Influence of immunomagnetic sorting on detecting genetic aberration of multiple myeloma cells by interphase fluorescence in situ hybridization]
Gang An, Cheng-Wen Li, Qian Li, et al.
Cancers
|
August 28, 2025
Development of a Cytogenetic Double-Hit Model for Survival Prediction in Multiple Myeloma
Chenxing Du, Jian Cui, Jingyu Xu, et al.
Apoptosis : an International Journal on Programmed Cell Death
|
December 28, 2006
Identification of poly-reactive natural IgM antibody that recognizes late apoptotic cells and promotes phagocytosis of the cells
Meng Fu, Ping-shen Fan, Wei Li, et al.
Biomarker Research
|
April 8, 2025
A novel indirubin- 3-monoxime derivative I3MV- 8b exhibits remarkable cytotoxicity against multiple myeloma by targeting TRIM28
Teng Fang, Lanting Liu, Hao Sun, et al.
Frontiers in Medicine
|
June 29, 2026
Disease characteristics, treatment, and outcomes in Chinese chronic lymphocytic leukemia patients following BTK inhibitor discontinuation: a multicenter real-world study
Yuting Yan, Wei Wang, Xiaojing Yan, et al.
Molecular Cell
|
November 5, 2004
Structural basis for androgen receptor interdomain and coactivator interactions suggests a transition in nuclear receptor activation function dominance
Bin He, Robert T Gampe, Adam J Kole, et al.
Page
of 28
Search research articles
Search
Showing results (151-160 of 274) with videos related to
Sort By:
Page
of 28
Clinical Lymphoma, Myeloma & Leukemia
|
June 1, 2010
Comparison among immunologically different subtypes of 595 untreated multiple myeloma patients in northern China
Li Zhang, Jun-Yuan Qi, Pei-Jing Qi, et al.
Zhongguo Shi Yan Xue Ye Xue Za Zhi
|
June 18, 2019
[Clinical Analysis of B-CLPD with Cytopemia as the Predominant Characteristic]
Rui Lu, Zeng-Jun Li, Gang An, et al.
JAMA Network Open
|
December 1, 2023
Whole-Exome Sequencing Among School-Aged Children With High Myopia
Xiangyi Yu, Jian Yuan, Zhen Ji Chen, et al.
Blood Advances
|
September 3, 2025
Monoclonal gammopathy defines distinct clinical subsets in Chronic Lymphocytic Leukemia across therapeutic eras
Yuting Yan, Bolin Yuan, Tonglu Qiu, et al.
Zhongguo Shi Yan Xue Ye Xue Za Zhi
|
March 3, 2011
[Influence of immunomagnetic sorting on detecting genetic aberration of multiple myeloma cells by interphase fluorescence in situ hybridization]
Gang An, Cheng-Wen Li, Qian Li, et al.
Cancers
|
August 28, 2025
Development of a Cytogenetic Double-Hit Model for Survival Prediction in Multiple Myeloma
Chenxing Du, Jian Cui, Jingyu Xu, et al.
Apoptosis : an International Journal on Programmed Cell Death
|
December 28, 2006
Identification of poly-reactive natural IgM antibody that recognizes late apoptotic cells and promotes phagocytosis of the cells
Meng Fu, Ping-shen Fan, Wei Li, et al.
Biomarker Research
|
April 8, 2025
A novel indirubin- 3-monoxime derivative I3MV- 8b exhibits remarkable cytotoxicity against multiple myeloma by targeting TRIM28
Teng Fang, Lanting Liu, Hao Sun, et al.
Frontiers in Medicine
|
June 29, 2026
Disease characteristics, treatment, and outcomes in Chinese chronic lymphocytic leukemia patients following BTK inhibitor discontinuation: a multicenter real-world study
Yuting Yan, Wei Wang, Xiaojing Yan, et al.
Molecular Cell
|
November 5, 2004
Structural basis for androgen receptor interdomain and coactivator interactions suggests a transition in nuclear receptor activation function dominance
Bin He, Robert T Gampe, Adam J Kole, et al.
Page
of 28